z-logo
open-access-imgOpen Access
An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
Author(s) -
Vikas Talreja,
Vanita Noronha,
Amit Joshi,
Vijay Patil,
Kumar Prabhash
Publication year - 2019
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/sajc.sajc_157_19
Subject(s) - medicine , olaparib , ovarian cancer , license , oncology , paclitaxel , cancer research , cancer , genetics , gene , polymerase , political science , law , poly adp ribose polymerase , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom